Keeping up with the science: Innovation in the health and care system post Brexit
Article
Innovation in health – new treatments, technologies and processes – can help drive improvements in healthcare and ultimately health outcomes. We are on the cusp of a new wave of innovation driven by robotics, big data and therapeutic breakthroughs such as cell and gene therapy.
However, the history of innovation in the UK shows that the health and care system is often slow to adopt new technologies. The government has tried to address the causes of this problem, most recently through the Accelerated Access Review (AAR) and Life Sciences (Industrial) Strategy.
Although these initiatives offer a number of sensible policy suggestions, the reality is that they will fail to deliver on their potential without a Brexit deal that prioritises health and care; a new long-term funding settlement for health and care; and a clear plan for system reform in the NHS.
Related items
From bystander to builder: government guidance will be essential for industry to thrive
Global political attention remains fixed on Washington. US president Donald Trump’s tariffs (and the circling threat of new tariffs) are challenging the global economic order and throwing governments into chaos. Intensifying economic…Accountability matters: Securing the future of devolution
English local government faces major reshaping.Nuclear enrichment: Building a stable and effective nuclear workforce
The government has talked a good game on the future of nuclear generation.